Golden
Kite Pharma

Kite Pharma

A company focused on delivering cure for cancer using engineered T cell therapy

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

May 2013

Kite Pharma raises a $15,000,000 series A round from David Bonderman, Alta Partners, Pontifax Venture Capital, Michael Milken and Commercial Street Capital.

December 20, 2012

Kite Pharma raises a $250,000 seed round.

March 9, 2011

Kite Pharma raises a $15,000,000 series A round.

Funding rounds

People

Name
Role
LinkedIn

Adam Smith

Founder



Alexandra Stanley

Employee



Amit Patel

Investor



Andy Park

Employee



Brendan McDonnell

Employee



Brian Jackson

Employee



Caelan Urquhart

Employee



Cara Debbaudt

Employee



Dane Bratz

Employee



Daniel Hung

Employee



Debra Susarchick

Employee



Devan Zappia

Employee



Drew Houston

Investor



Emmett Shear

Investor



Kyle Vogt

Investor



Lee Linden

Advisor



Linsey Fisher

Employee



Liza Jardiolin

Employee



Mario de Vera

Employee



Max Levchin

Investor



Oliver Valle

Employee



Reddy Kal

Employee



Robert Castellanos

Employee



Robert Crater

Employee



Robert T Chang

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services